Route of drug use and its implications for drug effect, risk of dependence and health consequences

References

• Des Jarlais DC, Friedman S. AIDS and i.v. drug use. Science 1989; 245: 578–579
   PubMed Web of Science ®Google Scholar
• AIDS and drug misuse: the challenge for policy and practice in the 1990s, J Strang, G Stimson. Routledge, London 1990
   Google Scholar
• Mann J, Tarantola J, Netter T. AIDS in the world. Harvard University Press, Cambridge, Mass. 1992
   Google Scholar
• Des Jarlais DC, Stimson GV, Hagan H, Perlman D, Choopanya K, Bastos F, Friedman S. Emerging infectious diseases and the injection of illicit psychoactive drugs. Curr Issues Public Health 1996; 2: 130–137
   Google Scholar
• Needle sharing among intravenous drug abusers: national and international perspectives, NIDA Research Monograph, R Battjes, R Pickens. National Institute on Drug Abuse, Rockville, Maryland 1998; 80
   Google Scholar
• Robertson R. The Edinburgh epidemic: a case study. AIDS and drug misuse: the challenge for policy and practice in the 1990s, J Strang, G Stimson. Routledge, London 1990; 95–107, In
   Google Scholar
• Des Jarlais DC. The first and second decades of AIDS among injecting drug users. Br J Addict 1992; 87: 347–354
   PubMedGoogle Scholar
• Gossop M, Griffiths P, Powis B, Williamson S, Fountain J, Strang J. Continuing drug risk behaviour: shared use of injecting paraphernalia among London heroin injectors. AIDS Care 1997; 9: 651–660
   PubMed Web of Science ®Google Scholar
• Heathcote J, Sherlock S. Spread of acute type B hepatitis in London. Lancet 1973; 2: 1468–1470
   Google Scholar
• Bortolotti F, Cadrobbi P, Crivellaro C, Menenghetti F, Carretta M, Stivanello A, de Rossi A, Noventa F. The changing epidemiology of acute type B hepatitis: results of an 11 year prospective study in Padua, Northern Italy. Infection 1989; 17: 364–368
   PubMedGoogle Scholar
• Crofts N, Hopper JL, Bowden DS, Breshkin AM, Milner R, Locarnini SA. Hepatitis C virus infection among a cohort of Victorian injecting drug users. Med J Aust 1993; 159: 237–241
   PubMed Web of Science ®Google Scholar
• Van den Hork JAR, Van Haastrecht HJA, Goudsmidt J, de Wolf F, Coutinho RA. Prevalence, incidence, and risk factors for hepatitis C infection amongst drug users in Amsterdam. J Infect Dis 1990; 162: 823–826
   PubMedGoogle Scholar
• Alter M. The detection, transmission and outcome of hepatitis C virus infection. Infect Agents Dis 1993; 2: 155–166
   PubMedGoogle Scholar
• Neelemann J, Farrell M. Hepatitis C amongst drug injectors: psychosocial impact similar to that of HIV infection. Br Med J 1994; 308: 1710–1710
   Google Scholar
• Raimondo G, et al. Multicentre study of prevalence of HPV-associated delta infection and liver disease in drug addicts. Lancet 1982; 1: 249–251
   PubMed Web of Science ®Google Scholar
• Kunches LM, et al. Seroprevalence of hepatitis B virus and delta agent in parenteral drug abusers: immunogenicity of hepatitis B vaccine. Am J Med 1986; 81: 591–595
   PubMedGoogle Scholar
• Smith H, Alexander GJ, Webb G, McManus T, McFarlance IG, Williams R. Hepatitis B and delta virus infection amongst “at risk” populations in South East London. J Epidemiol Commun Health 1992; 46: 144–147
   PubMedGoogle Scholar
• Aikawa T, Sugai Y, Okamato H. Hepatitis G infection in drug users with hepatitis C. N Eng J Med 1996; 334: 195–196
   PubMed Web of Science ®Google Scholar
• Gossop M, Griffith P, Powis B, Williamson S, Strang J. Frequency of non-fatal heroin overdose: survey of heroin users recruited in non-clinical settings. BMJ 1996; 313: 402–402
   PubMed Web of Science ®Google Scholar
• Tashkin DP, Simmons MS, Caulson AH, Clark VA, Gong H. Respiratory effects of cocaine free-basing among habitual users of marijuana with or without tobacco. Chest 1987; 92: 638–644
   PubMed Web of Science ®Google Scholar
• Gordon K. Freebase cocaine smoking and reactive airway disease. J Emerg Med 1989; 7: 145–147
   PubMedGoogle Scholar
• Jeri FR, Sanchez CC, Del Pozo T, Fernandez M, Carbajal C. Further experience with the syndromes produced by coca paste smoking. Cocaine, FR Jeri. Pacific Press, Lima 1980; 76–85, 1980
   Google Scholar
• Negrete J-C. The Andean region of South America: indigenous coca chewing in the rural areas and coca paste smoking in the cities. Drug problems in the sociocultural context: a basis for policies and programme planning, G Edwards, A Arif. World Health Organization, Geneva 1980; 56–63, In
   Google Scholar
• Oliver RM. Broncospasm and heroin inhalation. Lancet 1986; 1: 915–915
   PubMedGoogle Scholar
• Del Los Santos Sastre S, Capote-Gil F, Gonzalez-Castro A. Airway obstruction and heroin inhalation. Lancet 1986; 2: 1159–1159
   Google Scholar
• Hughes S, Calverley PM. Heroin inhalation and asthma. Br Med J 1988; 297: 1511–1512
   PubMed Web of Science ®Google Scholar
• Wolters E, Stam F, Lousberg RJ, Van Wijngaarden GK, Rengelink H, Schipper M, Verbeeten B. Leuco-encephalopathy after inhaling “heroin” pyrolysate. Lancet 1982; ii: 1233–1237
   Google Scholar
• Stam FC. Leucoencephalopathies due to intoxications. Handbook of clinical neurology Vol. 3. Demyelination diseases, PJ Vinken, G Bryn. Elsevier Science Publishers, Amsterdam 1985; 551–581, In
   Google Scholar
• Edwards G. Drugs and drug dependence. Drug use and misuse: cultural perspectives, G Edwards, A Arif, J Jaffe. Croom Helm, Beckenham, Kent 1983; 7–17, In
   Google Scholar
• Richardson BW. Diseases of modern life. Fowler and Wells, New York 1883
   Google Scholar
• Twycross RG. Choice of strong analgesic in terminal cancer: diamorphine or morphine. Pain 1977; 3: 93–104
   PubMed Web of Science ®Google Scholar
• Inturrisi CE. Pharmacokinetics of oral, intravenous and continuous infustions of heroin. Opioid analgesics in the management of clinical pain, KM Foley, EC Inturrisi. Raven, New York 1986; 117–127, In
   Google Scholar
• Inturrisi CE, Foley KM. Narcotic analgesics in the management of pain. Analgesics: neurochemical, behavioural, and clinical perspectives, M Kumar, G Pasternak. Raven, New York 1984; 257–288, In
   Google Scholar
• Inturrisi CE, Mitchell M, Foley KM, Schultz M, Shin S, Houde RW. The pharmacokinetics of heroin in patients with chronic pain. N Engl J Med 1984; 310: 1213–1217
   PubMed Web of Science ®Google Scholar
• Jaffe JH, Martin WR. Opioid analgesics and antogonists. The pharmacological basis of therapeutics, JG Hardman, LE Linbird, PB Molinoff, RW Ruddon, AG Gilman. Macmillan, New York 1980; 494–534, In
   Google Scholar
• Brunk SF, Delle M. Morphine metabolism in man. Clin Pharmacol Ther 1974; 16: 51–57
   PubMed Web of Science ®Google Scholar
• Martin WR, Sloane JW. Neuropharmacology and neurochemistry of subjective effects, analgesia, tolerance and dependence produced by narcotic analgesics. Drug addiction 1: morphine sedative, hypnotic and alcohol dependence, Handbook of Experimental Pharmacology, WR Martin. Springer Verlag, Berlin 1977; 45: 43–158, In
   Google Scholar
• Findlay JWA, Jones EC, Butz RF, Welch RM. Plasma codeine and morphine concentrations after therapeutic oral doses of codeine-containing analgesics. Clin Pharmacol Ther 1978; 24: 60–68
   PubMed Web of Science ®Google Scholar
• Beaver WT, Wallenstein SL, Houde RW, Rogers A. A clinical comparison of the analgesic effects of methadone and morphine adminstered intramuscularly and of orally and parenterally administered methadone. Pharmacol Ther 1967; 8: 415–425
   Google Scholar
• Martin WR, Jasinski DR, Haertzen C, Kay D, Jones BE, Mansky P, Carpenter R. Methadone—a reevaluation. Arch Gen Psychiatr 1973; 28: 286–295
   PubMed Web of Science ®Google Scholar
• Twycross RG, Fry DE, Wills PD. The alimentary absorption of diamorphine and morphine in man as indicated by urinary excretion studies. Br J Clin Pharmacol 1974; 1: 491–497
   PubMedGoogle Scholar
• Aherne GW, Marks V, Morris BA, Piall EM, Robinson JD, Twycross RG. The measurement of serum morphine levels by radioimmunoassay following oral administration of diamorphine or morphine. Br J Pharmacol 1975; 54: 228–238
   Google Scholar
• Stevans L, Wootten C. The pharmacokinetic properties of diamorphine. Diamorphine: its chemistry, pharmacology and clinical use, DB Scott. Woodland Faulkner, London 1988; 15–43, In
   Google Scholar
• Jones VA, Hanks GW. New portable infustion pump for prolonged subcutaneous administration of opioid analgesics in patients with advanced cancer. Br Med J 1986; 292: 1496–1498
   PubMedGoogle Scholar
• Inturrisi CE, Schultz M, Shin S, Umans JG, Angel L, Simon EJ. Evidence from opiate binding studies that heroin acts through its metabolites. Life Sci 1983; 33: 773–776
   PubMed Web of Science ®Google Scholar
• Mo BP, Way EL. Assessment of inhalation as a mode of administration of heroin by addicts. J Pharmacol Exp Ther 1966; 154: 142–151
   PubMed Web of Science ®Google Scholar
• Huizer H. Analytical studies on illicit heroin: 5-efficacy of volatilisation during heroin smoking. Pharmaceut Weekblad Scientific edn 1987; 9: 203–211
   PubMedGoogle Scholar
• Strang J, Griffiths P, Gossop M. Heroin in the UK: different forms, different origins, and the relationship to different routes of administration. Drug Alcohol Rev 1997; 16: 329–337
   PubMed Web of Science ®Google Scholar
• Gruhzit CC. Pharmacological investigation and evaluation of the effects of combined barbiturate and heroin inhalation by addicts. Bull Narcotics 1958; 10: 8–11
   Google Scholar
• Huizer H. Efficacy of volatilisation during heroin smoking. Anal Stud Illicit Heroin. Ministry of Justice, Netherlands 1988; 107–126
   Google Scholar
• Cousins MJ, Mather LE. Intrathecal and epidural administration of opioids. Anaesthesiology 1984; 61: 276–280
   PubMed Web of Science ®Google Scholar
• Phillips DM, Moore RA, Bullingham RES, Allen MC, Baldwin D, Fisher A, Lloyd JW, McQuay HJ. Plasma morphine concentrations and clinical effects after thoracic extra dural morphine or diamorphine. Br J Anaesth 1984; 56: 829–835
   PubMedGoogle Scholar
• Bullingham RES, McQuay HJ, Moore RA, Bennett MRD. Buprenorphine kinetics. Clin Pharmacol Ther 1980; 28: 667–672
   PubMed Web of Science ®Google Scholar
• Bullingham RES, McQuay HJ, Dwyer Allen MC, Moore RA. Sublingual buprenorphine used post-operatively: clinical observations and preliminary pharmacokinetic analysis. Br J Clin Pharmacol 1981; 12: 117–122
   PubMed Web of Science ®Google Scholar
• Eriksen J, Gensen N-H, Camp-Gensen M, Bjarno H, Friis P, Brewster D. The systemic availability of buprenorphine administered by nasal spray. J Pharmacol 1989; 41: 803–805
   Google Scholar
• Strang J. Abuse of buprenorphine (Temgesic). Lancet 1985; 2: 1401–1401
   PubMedGoogle Scholar
• Hammersley R, et al. Buprenorphine and temazepam abuse. Br J Addict 1990; 85: 301–303
   PubMedGoogle Scholar
• Strang J. New abuse of buprenorphine by snorting (Drug Points). Br Med J 1991; 302: 969–969
   PubMed Web of Science ®Google Scholar
• Verebey K, Gold M. From coca leaves to crack: the effects of dose and routes of administration in abuse liability. Psychiatr Ann 1988; 18: 513–520
   Google Scholar
• Van Dyke C, Barash PG, Jatlow P, et al. Cocaine: plasma concentrations after intranasal application in man. Science 1976; 191: 859–886
   PubMed Web of Science ®Google Scholar
• Van Dyke C, Jatlow P, Ungerer J, et al. Oral cocaine: plasma concentrations and central effects. Science 1978; 200: 211–213
   PubMed Web of Science ®Google Scholar
• Resnick RB, Kestenbaum RS, Schwartz K. Acute systemic effects of cocaine in man: a controlled study by intranasal and intravenous routes. Science 1977; 195: 696–698
   PubMed Web of Science ®Google Scholar
• Holmsteadt B, Lindgren JE, Rivier L. Cocaine in blood of coca chewers. J Ethnopharmacol 1979; 1: 69–78
   PubMedGoogle Scholar
• Wilkinson P, Van Dyke C, Jatlow P, et al. Intranasal and oral cocaine kinetics. Clin Pharmacol Ther 1980; 27: 386–394
   PubMed Web of Science ®Google Scholar
• Paly D, Van Dyke C, Jatlow P, . Cocaine: plasma levels after cocaine paste smoking. Cocaine, FR Jeri, et al. Pacific Press, Lima 1980; 106–110, 1980
   Google Scholar
• Paly D, Jatlow P, Van Dyke C, Jeri FR, Byck R. Plasma cocaine concentrations during cocaine paste smoking. Life Sci. 1982; 30: 731–738
   PubMed Web of Science ®Google Scholar
• Perez-Reys M, di Guiseppi S, Ondrusek G, Jeffcoat AR, Cooke CE. Freebase cocaine smoking. Clin Pharmacol Ther. 1982; 32: 459–465
   PubMedGoogle Scholar
• Cooke CE. Pyroltic characteristics pharmacokinetics and bioavailability of smoke heroin, cocaine, phencyclidine and methamphetamine. Methamphetamine abuse: epidemiologic issues and implications, NIDA Research Monograph. NIDA, National Institute on Drug Abuse, Maryland 1991; 115, In
   Google Scholar
• Jeffcoat AR, Perez-Reys M, Hill JM, Sadler BM, Cooke CE. Cocaine disposition in humans after intravenous injection, nasal insuflation (snorting), or smoking. Drug Metab Disposition 1989; 17: 153–159
   PubMed Web of Science ®Google Scholar
• Martin BR, Lue LP, Bonni JP. Pyrolysis and volatilisation of cocaine. J Analy Toxicol 1989; 13: 158–162
   PubMed Web of Science ®Google Scholar
• Fischman M, Schuster C, Resnekov L, Shick J, Krasnegor NA, Fennell W, Freedman D. Cardiovascular and subjective effects of intravenous cocaine administration in humans. Arch Gen Psychiatr 1976; 33: 983–989
   PubMed Web of Science ®Google Scholar
• Fischman MW, Foltin RW. Self-administration of cocaine by humans: a laboratory perspective. Cocaine: scientific and social dimensions, CIBA Foundation Symposium Report, G Edwards. John Wiley, Chichester 1992; 166: 165–173, In
   Google Scholar
• Kerr N. Inebriety: its etiology, pathology, treatment and jurisprudence. Lewis, London 1889
   Google Scholar
• Kolb L. Pleasure and deterioration from narcotic addiction. Mental Hygiene 1925; 60: 699–724
   Google Scholar
• Fort JP. Heroin addiction among young men. Psychiatry 1954; 17: 251–259, [Reprinted in: O'Donnell & Ball, eds. Narcotic Addict. 1966; New York: Harper and Row, 1966;76–91.
   PubMed Web of Science ®Google Scholar
• Oldendorf W. Some relationships between addiction and drug delivery to the brain. Bioavailability of drugs to the brain and the blood-brain barrier, Research Monograph, J Frankenheim, R Brown. National Institute of Drug Abuse, Rockville, Maryland 1992; 120: 13–25, In
   Google Scholar
• Oldendorf WH, Hyman S, Braun L, Oldendorf SZ. Blood-brain barrier: penetration of morphine, codeine, heroin, and methadone after corotid injection. Science 1972; 178: 984–986
   PubMed Web of Science ®Google Scholar
• Jones RT. Psychopharmacology of cocaine. Cocaine: a clinicians handbook, AM Washton, MS Gold. Guilford Press, New York 1987; 55–72, In
   Google Scholar
• Boerner U, Abbott S, Roe RL. The metabolism of morphine and heroin in man. Drug Metab Rev 1975; 4: 39–49
   PubMed Web of Science ®Google Scholar
• Byck R, Van Dyke C. What are the effects of cocaine in man?. Cocaine, RC Petersen, RC Stillman. National Institute on Drug Abuse, Rockville, Maryland 1977; 97–117, 1977
   Google Scholar
• Cocaine 1980, Proceedings of the Inter-American Seminar on Medical and Sociological Aspects of Coca and Cocaine, FR Jeri. Pacific Press, Lima 1980
   Google Scholar
• Winger GD, Woods JH. The reinforcing property of ethanol in the Rhesus monkey: No. 1. Initiation, maintenance and termination of intravenous ethanol-reinforced responding. Ann NY Acad Sci 1973; 215: 162–175
   PubMed Web of Science ®Google Scholar
• Altschuler HL. Intragastric self-administration of ethanol: a sub-human primate model of alcoholism. Animal models in alcohol research, K Ericksson, JP Sinclair, K Kiianmaa. Academic Press, New York 1976; 179–184, In
   Google Scholar
• Schuster CR, Johanson CE. An analysis of drug-seeking behaviour in animals. Neurosci Biobehav Rev 1981; 5: 315–323
   PubMedGoogle Scholar
• Behavioural analysis of drug dependence, SR Goldburg, I Stolerman. Academic Press, Orlando 1986
   Google Scholar
• Neuman R. Multiple exposures to ethanol facilitate intravenous self-administration of ethanol by rats. Pharmacol Biochem Behav 1981; 15: 101–108
   PubMedGoogle Scholar
• Meisch RA. Alcohol self-administration by experimental animals. Research advances in alcohol and drug problems, R Smart, et al. Plenum Press, New York 1984; 23–45, In
   Google Scholar
• Cappell H, Le Blanc AE. Tolerance to, and physical dependence on, ethanol: Why do we study them?. Drug Alcohol Depend 1979; 4: 15–31
   PubMedGoogle Scholar
• Grant K, Hoffman P, Tabakoff B. Neurobiological and behavioural approaches to tolerance and dependence. The nature of drug dependence, G Edwards, M Lader. Oxford University Press, Oxford 1990; 135–162, In
   Google Scholar
• Schuster CR, Johanson CE. Behavioural analysis of opiate dependents. Opiate addiction: origins and treatment, S Fischer, AM Freedman. Winston, Washington 1973; 77–92, In
   Google Scholar
• Schuster CR. Drug-seeking behaviour: implications for theories of drug dependence. The nature of drug dependence, G Edwards, M Lader. Oxford University Press, Oxford 1990; 171–193, In
   Google Scholar
• Jaffe JH, Martin WR. Drugs of abuse. The pharmacological basis of therapeutics, LS Goodman, A Gilman. Macmillan, New York 1975; 245–283, In
   Google Scholar
• Jones BE, Prada JA. Relapse to morphine use in dog. Psychopharmacologia 1973; 30: 1–12
   PubMed Web of Science ®Google Scholar
• Schuster CR, Johanson CE. The use of animal models for the study of drug abuse. Research advances in alcohol and drug problems, RJ Gibbins, Y Israel, H Kalant, R Potham, W Schmidt, R Smart. John Wiley, New York 1974; 1–31, In
   Google Scholar
• Schuster CR. Drugs as reinforcers in monkey and man. Pharmacol Rev 1976; 27: 511–521
   Google Scholar
• Balster RL, Schuster CR. Fixed-interval schedule of cocaine reinforcement: effect of dose and infusion duration. J Exp Anal Behav 1973; 20: 119–129
   PubMed Web of Science ®Google Scholar
• Thompson T, Pickens R. Stimulant self-administration by animals: some comparisons with opiate self-administration. Fed Proc 1970; 29: 6–12
   PubMedGoogle Scholar
• Azrin NH, Holz WC. Punishment. Operant behaviour: areas of research and application, WK Honig. Appleton Century-Crofts, New York 1966; 380–447, In
   Google Scholar
• Smith SG, Davis WM. Punishment of amphetamine and morphine self-administration behaviour. Psychol Rec 1974; 24: 477–480
   Google Scholar
• Woods JH, Winger G. Behavioural characterisation of opioid mixed agonist-antagonists. Drug Alcohol Depend 1987; 20: 303–315
   PubMedGoogle Scholar
• Strang J, Griffiths P, Gossop M. Heroin smoking by “chasing the dragon”; origins and history. Addiction 1997; 92: 673–683
   PubMed Web of Science ®Google Scholar
• Westermeyer J. The pro-heroin effect of opium laws in Asia. Arch Gen Psychiatr 1976; 33: 435–435
   Google Scholar
• Sunwanwela C, Poshyachinda V. Thailand: traditional patterns of opium use and the emerging drug problems of urbanisation. Drug problems in the sociocultural context: a basis for policies and programme planning, G Edwards, A Arif. World Health Organization, Geneva 1980; 32–37, In
   Google Scholar
• Khant U, Win Ne. Burma: opium addicts and the new wave of heroin addicts compared. Drug problems in the sociocultural context: a basis for policies and programme planning, G Edwards, A Arif. World Health Organization, Geneva 1980; 54–55, In
   Google Scholar
• Gossop M. The detoxification of high dose heroin addicts in Pakistan. Drug Alcohol Depend 1989; 24: 143–150
   PubMed Web of Science ®Google Scholar
• Jeri FR, Sanchez CC, Del Pozo T, Fernandez M. The syndrome of coca paste: observations on a group of 158 patients in Lima. J. Psychodelic Drugs 1978; 10: 361–370
   Web of Science ®Google Scholar
• Kleber HD. The US Anti-drug prevention strategy: science and policy connection. Drugs, alcohol and tobacco: making the science and policy connections, G Edwards, J Strang, J Jaffe. Oxford University Press, Oxford 1993; 109–120, In
   Google Scholar
• Schuster CR, Gust SW. Cocaine: challenges to research. Drugs, alcohol and tobacco: making the science and policy connections, G Edwards, J Strang, J Jaffe. Oxford University Press, Oxford 1993; 146–155, In
   Google Scholar
• Methamphetamine abuse: epidemiologic issues and implications, NIDA Research Monograph, M Miller, N Kozel. National Institute on Drug Abuse, Rockville, Maryland 1991; 115
   Google Scholar
• De Alarcon R. The uses of clinical epidemiology. Studying drug abuse, LN Robins. Rutgers University Press, New Brunswick 1985; 25–45, In
   Google Scholar
• Wikler A. On the nature of addiction and habituation. Br J Addict 1961; 57: 73–79
   Google Scholar
• Thompson IG, Rathod NH. Aversion therapy for heroin dependents. Lancet 1968; ii: 382–383
   Google Scholar
• Coutwright D, Joseph H, Des Jarlais DC. Addicts who survived: an oral history of narcotic use in American 1923–1965. UNiversity of Tennessee Press, Knoxville 1989
   Google Scholar
• Siegel AJ. The heroin crisis among US forces in South East Asia. JAMA 1973; 223: 1258–1261
   PubMed Web of Science ®Google Scholar
• Kolb D, Nail RL, Gunderson EKE. Differences in family characteristics of heroin injectors and inhalers. J Nerv Mental Dis. 1974; 158: 446–449
   PubMedGoogle Scholar
• Smith DE. West Coast and East Coast drug abuse patterns (1979–1980). Recent developments in drug and alcohol abuse, Annals of the New York Academy of Sciences, RB Millman, P Cushman, JH Lowinson. New York Academy of Sciences, New York 1981; 362: 22–28, In
   Google Scholar
• Wesson DR, Washburn P. Current patterns of drug abuse that involve smoking. Research findings on smoking of abused substances, NIDA Research Monograph, CN Chiang, RL Hawks. National Institute on Drug Abuse, Rockville, Maryland 1990; 99: 5–11, In
   Google Scholar
• Pearson G. The new heroin users. Blackwell, Oxford 1987
   Google Scholar
• Gamella JF. The spread of intravenous drug use and AIDS in a neighbourhood in Spain. Med. Anthropol. Q. 1994; 8: 131–160
   Web of Science ®Google Scholar
• Blackwell J. Drifing, controlling and overcoming: opiate users who avoid becoming chronically dependent. J Drug Issues 1983; 13: 219–235
   Web of Science ®Google Scholar
• Blackwell J. Opiate dependence as a psychophysical event: users reports of subjective experiences. Contemp Drug Problems 1985; 12: 331–350
   Google Scholar
• Zinberg N. Drug, set and setting: the basis for controlled intoxicant use. Yale University Press, New Haven 1984
   Google Scholar
• Murphy S, Reinarman C, Waldorf D. An 11 years follow-up of a network of cocaine users. B J Addict. 1989; 84: 427–436
   PubMedGoogle Scholar
• Erickson CK, javors MA, Morgan WW. Drug dependence: defining the issues. Addiction potential of abused drugs and drug classes, CK Erickson, M Javors, W Morgan. Haworth Press, New York 1990, In
   Google Scholar
• Gossop M, Griffiths P, Powis B, Strang J. Severity of Dependence and route of administration of heroin, cocaine and amphetamines. Br J Addict 1992; 87: 1527–1536
   PubMedGoogle Scholar
• Strang J, Connell PH. Clinical aspects of drug and alcohol abuse. Child and adolescent psychiatry: modern approaches2nd edn., M Rutter, L Hersov. Blackwell Scientific Publications, Oxford 1985; 501–515, In
   Google Scholar
• Advisory Council on the Misuse of Drugs. Prevention report. Her Majesty's Stationery Office, London 1984
   Google Scholar
• Strang J, Griffiths P, Abbey J, Gossop M. Survey of use of injected benzodiazepines among drug users in Britain. Br Med J 1994; 308: 1082–1082
   PubMed Web of Science ®Google Scholar
• Stimson GV, Alldritt L, Dolan K, Donoghoe M. Syringe exchange schemes for drug users in England and Scotland. Br Med J 1988; 296: 1717–1719
   PubMed Web of Science ®Google Scholar
• Stimson G, Donoghoe M, Lart R, Dolan K. Distributing sterile needles and syringes to people who inject drugs: the syringe exchange experiment. AIDS and drug misuse, J Strang, G Stimson. Routledge, London 1990, In
   Google Scholar
• Cregler LL, Mark H. Medical complications of cocaine abuse. N Engl J Med 1986; 315: 1495–1500
   PubMed Web of Science ®Google Scholar
• Brogan WC, Langer A, Glamann DB, Hillis LD. Recurrent coronary vasoconstruction caused by intranasal cocaine: possible role for metabolites. Ann Intern Med 1992; 116: 556–561
   PubMed Web of Science ®Google Scholar
• Hollander JE, Hoffman RS. Cocaine-induced myocardial infarction: an analysis and review of the literature. J Emerg Med 1991; 10: 169–177
   Google Scholar
• D'Agostino RS, Arnett EN. Acute myoglobinuria and heroin snorting. J AMA 1979; 241–241, 277
   Google Scholar
• Annane D, Teboul JL, Richard CH. Severe rhabdomyolisis related to heroin sniffing. Intensive Care Med 1990; 16: 4410–4410
   Google Scholar
• Gonzalez Parra E, Ortiz A, Olague C, Caramelo C. Insuficiencia renal aguda secundaria a rabdomiolisis par inhalacion de heroina [Acute renal insufficiency following rhabdomyolysis from heroin inhalation]. Nephrologia 1992; 12: 175–176
   Google Scholar
• Anderson K. Bronchospasm and intravenous street heroin. Lancet 1986; 1: 1208–1208
   PubMedGoogle Scholar
• Ghodse AH, Myles J. Asthma in opiate addicts. J Psychosomatic Res 1987; 31: 41–44
   PubMed Web of Science ®Google Scholar
• Allred RJ, Ewer S. Fatal pulmonary oedema following intravenous freebase cocaine use. Ann Emerg Med 1981; 8: 441–442
   Google Scholar
• Cucco RA, Yoo OH, Cregler L, Chang JC. Nonphecal pulmonary oedema after freebase cocaine smoking. Am Rev Resp Dis 1987; 136: 179–181
   PubMed Web of Science ®Google Scholar
• Haan J, Muller E, Gerhard L. Spongiose Leukodystrophie nach Drogenmissbraauch. Nervenarzt 1983; 54: 489–490
   PubMedGoogle Scholar
• Schiffer D, Brignolio F, Giordana MT, Mongini T, Migheli A, Palmucci L. Spongiform encephalopathy in addicts inhaling pre-heated heroin. Clin Neuropathol 1985; 4: 174–180
   PubMed Web of Science ®Google Scholar
• Hungerbuhler H, Waespe W. Leukoenzephalopathie nach inhalation von heroin-pyrolysat [Leucoencepholopathy after inhalation of heroin pyrolysate]. Schweiz Med Wochenschr 1990; 120: 1801–1805
   PubMedGoogle Scholar
• Sempere AP, Posada I, Ramo C, Cabello A. Spongiform leucoencephalopathy after inhaling heroin. Lancet 1991; 338: 320–320
   PubMedGoogle Scholar
• Yeager RA, et al. Vascular complications related to drug abuse. J Trauma 1987; 27: 305–308
   PubMedGoogle Scholar
• Glassroth J, et al. The impact of substance abuse treatment on the respiratory system. Chest 1986; 91: 596–602
   Google Scholar
• McCarroll K, Roszler M. Lung disorders due to drug abuse. J Thorac Imaging 1991; 6: 30–35
   PubMed Web of Science ®Google Scholar
• Neugarten J, et al. Amyloidosis in subcutaneous heroin abusers (“skin poppers amyloidosis”). Am J Med 1986; 81: 635–640
   PubMed Web of Science ®Google Scholar
• Reisberg BE. Infective endocarditis in the narcotic addict. Prog Cardiovasc Dis 1979; 23: 193–204
   Google Scholar
• Adler M. AIDS and intravenous drug abusers. Br J Addict 1986; 81: 307–310
   PubMedGoogle Scholar
• Eulenburg A. Percutane intracutane und subcutane arzneiapplicationen. Handbuch der Allgemeien Therapie No. 1., H. von Ziemssen, Leipzig 1880, (cited in Howard-Jones). A critical study of the origins and early development of hypodermic medication. J Hist Med 1947;2:201–249.
   Google Scholar
• Biggam AG. Malignant malaria associated with the administration of heroin intravenously. Trans Roy Soc Trop Hygiene 1929; 23: 147–143
   Google Scholar
• Bulletin on Narcotics. History of heroin. Bull Narcotics 1953; 5: 3–16
   Google Scholar
• Appelbaum E, Gelfand B. The artificial transmission of malaria among intravenous diacetylmorphine addicts: preliminary notes on the use of atabine in malaria. J A M A 1934; 102: 1664–1670
   Google Scholar
• Helpern M. Epidemic of fatal aestivo-autumnal malaria among drug addicts in New York City transmitted by common use of hypodermic syringe. Am J Surg 1934; 26: 111–123
   Google Scholar
• Hussey H, Keliher TF, Schaefer BF, Walsh BJ. Septicaemia and bacterial endocarditis resulting from heroin addiction: report of five cases. J AMA 1944; 126: 535–538
   Google Scholar
• Appelbaum E, Kalkestein M. Artificial transmission of viral hepatitis among intravenous diacetylmorphine addicts. J A M A 1951; 147: 222–224
   PubMedGoogle Scholar
• Marks V, Chapple PAL. Hepatic dysfunction in heroin and cocaine users. Br J Addict 1967; 62: 189–195
   Google Scholar
• Bewley TH, Ben-Aire O, Marks V. Relation of hepatitis to self-injection techniques. Br Med J 1968; 1: 630–632
   Google Scholar
• Hunter J, Carrella M, Williams R, Taylor PE, Zuckerman AJ. The Australia (Hepatitis-associated) antigen among heroin addicts attending a London addiction clinic. J Hygiene 1971; 69: 565–570
   PubMedGoogle Scholar
• Zuckerman AJ. Hepatitis viruses. Oxford textbook of medicine, DJ Weatherall, JGG Ledingham, DA Warrell. Oxford University Press, Oxford 1983; 5–123, In
   Google Scholar
• Lettau LA, McCarthy JG, Smith MH, et al. Outbreak of severe hepatitis due to delta and hepatitis B viruses in parenteral drug abusers and their contacts. N Engl J Med 1987; 317: 1256–1262
   PubMedGoogle Scholar
• Carman W, Thomas H, Domingo E. Viral genetic variation: hepatitis B virus as a clinical example. Lancet 1993; 341: 349–353
   PubMedGoogle Scholar
• Kuo G, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244: 362–364
   PubMed Web of Science ®Google Scholar
• Alter MJ, et al. The natural history of community-acquired hepatitis C in the United States. N Engl J Med 1992; 327: 1899–1905
   PubMed Web of Science ®Google Scholar
• Mattsson L, et al. Chronic non-A, non-B hepatitis development after transfusions, illicit self-injections or sporadically: outcome during long-term follow-up—a comparison. Liver 1989; 9: 120–127
   PubMedGoogle Scholar
• Helpern M, Rho Y-M. Deaths from narcotism in New York City: incidence, circumstances and postmortem findings. Int J Addict 1967; 2: 53–84
   Web of Science ®Google Scholar
• Friedman C, Dover A, Roberto R, Kearns OA. A malaria epidemic among heroin users. Am J Trop Med Hygiene 1973; 22: 302–302
   PubMedGoogle Scholar
• Barata LCB, Andriguetti MT, De Malos MR. Surto de malaria induzida entre usuarios de drogas injetaveis [Outbreak of malaria among injectable-drug users]. Rev Saude Publica 1993; 27: 9–14
   PubMedGoogle Scholar
• Dunn J. Transmission of malaria by intravenous drug misuse. Psychiatr Bull 1994; 18: 423–424
   Google Scholar
• Des Jarlais DC, Friedman S. The epidemic of HIV infection among injecting drug users in New York City: the first decade and possible future directions. AIDS and drug misuse: the challenge for policy and practice in the 1990s, J Strang, G Stimson. Routledge, London 1990; 86–94, In
   Google Scholar
• Marmor M, Des Jarlais DC, Cohen HJ, et al. Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City. AIDS 1987; 1: 39–44
   PubMed Web of Science ®Google Scholar
• Tempesta E, Di Giantonio M. The Italian epidemic: a case study. AIDS and drug misuse: the challenge for policy and practice in the 1990s, J Strang, G Stimson. Routledge, London 1990; 108–117, In
   Google Scholar
• Brettle RP. Epidemic of AIDS related virus infection among intravenous drug abusers. Br Med J 1986; 292: 1671–1671
   PubMedGoogle Scholar
• Brettle RP, Bisset K, Burns S. Human immunodeficiency virus and drug use: the Edinburgh experience. Br Med J 1987; 295: 421–424
   PubMedGoogle Scholar
• Naik TN, Sarkar S, Singh HL, Bhunia SC, Singh YI, Singh PK, Pal SC. Intravenous drug users: a new high-risk group for HIV infection in India. AIDS 1991; 5: 117–118
   PubMed Web of Science ®Google Scholar
• Chaisson RE, Bacchetti P, Osmond P, Brodie B, Sante M, Moss AR. Cocaine use and HIV infection in intravenous drug users in San Francisco. JAMA 1989; 261: 561–565
   PubMed Web of Science ®Google Scholar
• Strang J, Powis B, Griffiths P, Gossop M. Heterosexual vaginal and anal intercourse amongst London heroin and cocaine users. Int J STD AIDS 1994; 5: 133–136
   PubMed Web of Science ®Google Scholar